CIK 0001404281
- Non-accelerated filer
- Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 150,000 shares at $15.00 ($2,250,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 237,500 shares at $15.00 ($3,562,500)
- 4 Conversion Director acquired 4,218,632 shares (conversion)
- 4 Open-market buy Director bought 362,500 shares at $15.00 ($5,437,500)
- 4 Open-market buy 10% owner bought 325,000 shares at $15.00 ($4,875,000)
- 4 Conversion Director acquired 121,077 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 54,604 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 10 of 11 · 212 filings